148 related articles for article (PubMed ID: 18827264)
1. Hemojuvelin N-terminal mutants reach the plasma membrane but do not activate the hepcidin response.
Pagani A; Silvestri L; Nai A; Camaschella C
Haematologica; 2008 Oct; 93(10):1466-72. PubMed ID: 18827264
[TBL] [Abstract][Full Text] [Related]
2. Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis.
Silvestri L; Pagani A; Fazi C; Gerardi G; Levi S; Arosio P; Camaschella C
Blood; 2007 May; 109(10):4503-10. PubMed ID: 17264300
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.
Babitt JL; Huang FW; Wrighting DM; Xia Y; Sidis Y; Samad TA; Campagna JA; Chung RT; Schneyer AL; Woolf CJ; Andrews NC; Lin HY
Nat Genet; 2006 May; 38(5):531-9. PubMed ID: 16604073
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor alpha downregulates human hemojuvelin expression via a novel response element within its promoter.
Salama MF; Bayele HK; Srai SS
J Biomed Sci; 2012 Sep; 19(1):83. PubMed ID: 22998440
[TBL] [Abstract][Full Text] [Related]
5. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin.
Lin L; Goldberg YP; Ganz T
Blood; 2005 Oct; 106(8):2884-9. PubMed ID: 15998830
[TBL] [Abstract][Full Text] [Related]
6. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.
Silvestri L; Pagani A; Nai A; De Domenico I; Kaplan J; Camaschella C
Cell Metab; 2008 Dec; 8(6):502-11. PubMed ID: 18976966
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin downregulation by repeated bleeding is not mediated by soluble hemojuvelin.
Krijt J; Fujikura Y; Sefc L; Vokurka M; Hlobenová T; Necas E
Physiol Res; 2010; 59(1):53-59. PubMed ID: 19249912
[TBL] [Abstract][Full Text] [Related]
8. Hemojuvelin-neogenin interaction is required for bone morphogenic protein-4-induced hepcidin expression.
Zhang AS; Yang F; Wang J; Tsukamoto H; Enns CA
J Biol Chem; 2009 Aug; 284(34):22580-9. PubMed ID: 19564337
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle hemojuvelin is dispensable for systemic iron homeostasis.
Chen W; Huang FW; de Renshaw TB; Andrews NC
Blood; 2011 Jun; 117(23):6319-25. PubMed ID: 21493799
[TBL] [Abstract][Full Text] [Related]
10. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism.
Andriopoulos B; Corradini E; Xia Y; Faasse SA; Chen S; Grgurevic L; Knutson MD; Pietrangelo A; Vukicevic S; Lin HY; Babitt JL
Nat Genet; 2009 Apr; 41(4):482-7. PubMed ID: 19252486
[TBL] [Abstract][Full Text] [Related]
11. Hemojuvelin is essential for transferrin-dependent and transferrin-independent hepcidin expression in mice.
Bartnikas TB; Fleming MD
Haematologica; 2012 Feb; 97(2):189-92. PubMed ID: 21993681
[TBL] [Abstract][Full Text] [Related]
12. Selective binding of RGMc/hemojuvelin, a key protein in systemic iron metabolism, to BMP-2 and neogenin.
Kuns-Hashimoto R; Kuninger D; Nili M; Rotwein P
Am J Physiol Cell Physiol; 2008 Apr; 294(4):C994-C1003. PubMed ID: 18287331
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD.
Casanovas G; Mleczko-Sanecka K; Altamura S; Hentze MW; Muckenthaler MU
J Mol Med (Berl); 2009 May; 87(5):471-80. PubMed ID: 19229506
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes.
Ramey G; Deschemin JC; Vaulont S
Haematologica; 2009 Jun; 94(6):765-72. PubMed ID: 19454495
[TBL] [Abstract][Full Text] [Related]
15. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele.
Biasiotto G; Roetto A; Daraio F; Polotti A; Gerardi GM; Girelli D; Cremonesi L; Arosio P; Camaschella C
Blood Cells Mol Dis; 2004; 33(3):338-43. PubMed ID: 15528154
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin.
Schmidt PJ; Andrews NC; Fleming MD
Blood; 2010 Dec; 116(25):5679-87. PubMed ID: 20837779
[TBL] [Abstract][Full Text] [Related]
17. Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis.
Lee DH; Zhou LJ; Zhou Z; Xie JX; Jung JU; Liu Y; Xi CX; Mei L; Xiong WC
Blood; 2010 Apr; 115(15):3136-45. PubMed ID: 20065295
[TBL] [Abstract][Full Text] [Related]
18. Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness.
Truksa J; Lee P; Beutler E
Blood; 2009 Jan; 113(3):688-95. PubMed ID: 18997172
[TBL] [Abstract][Full Text] [Related]
19. Liver hemojuvelin protein levels in mice deficient in matriptase-2 (Tmprss6).
Krijt J; Fujikura Y; Ramsay AJ; Velasco G; Nečas E
Blood Cells Mol Dis; 2011 Aug; 47(2):133-7. PubMed ID: 21612955
[TBL] [Abstract][Full Text] [Related]
20. A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells.
Verga Falzacappa MV; Casanovas G; Hentze MW; Muckenthaler MU
J Mol Med (Berl); 2008 May; 86(5):531-40. PubMed ID: 18421430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
